Newborn screening in the Asia Pacific region

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of Inherited Metabolic Disease

• Publication date

  2007-07-23

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10545-007-0687-7PMID 17643195
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Newborn screening in Bangladesh.

  2008influential reference
• More evidence to favour newborn screening for cystic fibrosis.

  2007cited by this paper
• Outcome of neonatal screening for medium-chain acyl-CoA dehydrogenase deficiency in Australia: a cohort study.

  2007cited by this paper
• National evaluation of US newborn screening system components.

  2006cited by this paper
• Newborn screening for lysosomal storage disorders.

  2006cited by this paper
• Tandem mass neonatal screening in Taiwan--report from one center.

  2006cited by this paper
• Neonatal screening for Glucose-6-Phosphate dehydrogenase deficiency

  2005cited by this paper
• Newborn screening in India

  2004influential reference
• Newborn screening in Korea.

  2003cited by this paper
• Neonatal screening in Hong Kong and Macau.

  2003cited by this paper
• Screening newborns for inborn errors of metabolism by tandem mass spectrometry.

  2003cited by this paper
• Mass newborn screening in Singapore.

  2003influential reference
• Neonatal screening program in Thailand.

  2003cited by this paper
• Neonatal screening and monitoring system in Taiwan.

  2003cited by this paper
• National neonatal hypothyroid screening program in Mongolia.

  2003cited by this paper
• Screening for congenital hypothyroidism--a new era in Bangladesh.

  2003influential reference
• Quality control system for mass screening in Japan.

  2003cited by this paper
• Newborn screening: experience of Bangladesh.

  2003cited by this paper
• Newborn screening in the Philippines.

  2003influential reference
• Newborn screening in Indonesia.

  2003influential reference
• Quality assurance program for neonatal screening of glucose-6-phosphate dehydrogenase deficiency.

  2003cited by this paper
• Newborn screening in Japan.

  2003influential reference
• Development of a newborn screening laboratory quality assurance system in Shandong, China.

  2003cited by this paper
• A Review of the Case for Neonatal Thyrotropin Screening in Developing Countries: The Example of India

  2002cited by this paper
• Newborn screening: rationale for a comprehensive, fully integrated public health system.

  2002cited by this paper
• U.S. newborn screening policy dilemmas for the twenty-first century.

  2001influential reference
• Newborn Screening Policy Dilemmas for the Twenty-First Century

  2001cited by this paper
• Serving the family from birth to the medical home. Newborn screening: a blueprint for the future - a call for a national agenda on state newborn screening programs

  2000cited by this paper
• US newborn screening system guidelines II: follow-up of children, diagnosis, management, and evaluation. Statement of the Council of Regional Networks for Genetic Services (CORN).

  2000influential reference
• Newborn screening with tandem mass spectrometry: 12 months' experience in NSW Australia

  1999cited by this paper
• Newborn screening in Singapore.

  1999cited by this paper
• Mass newborn screening for glucose-6-phosphate dehydrogenase deficiency in Singapore.

  1999cited by this paper
• Neonatal diagnosis of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency and implications for newborn screening by tandem mass spectrometry

  1999cited by this paper
• Neonatal screening in Australia.

  1999influential reference
• Robert Guthrie: The PKU Story

  1998cited by this paper
• Neonatal screening for cystic fibrosis: a comparison of two strategies for case detection in 1.2 million babies.

  1995cited by this paper
• New Trends in Neonatal Screening

  1994cited by this paper
• Inborn errors of amino acid metabolism in North India

  1994cited by this paper
• U.S. newborn screening system guidelines: Statement of the council of regional networks for genetic services

  1992cited by this paper
• The origin of newborn screening.

  1992influential reference
• Neonatal screening for amino acidaemias in Karnataka, South India

  1988cited by this paper
• The state of the world’s children

  1988cited by this paper
• A simple method for quantification of biotinidase activity in dried blood spot and its application to screening of biotinidase deficiency.

  1987cited by this paper
• Screening for Cystic Fibrosis

  1987cited by this paper
• Glucose-6-phosphate dehydrogenase deficiency: a preventable cause of mental retardation.

  1986cited by this paper
• Reduced morbidity in patients with cystic fibrosis detected by neonatal screening.

  1985cited by this paper
• New-born screening for aminoacidopathies in South India

  1983cited by this paper
• Screening for cystic fibrosis.

  1983cited by this paper
• System of Neonatal Screening for Inborn Errors of Metabolism in Japan

  1980influential reference
• Neonatal Screening for Inborn Errors of Metabolism

  1980cited by this paper
• Urine screening for aminoacidopathies: is it beneficial? Results of a long-term follow-up of cases detected bny screening one millon babies.

  1980cited by this paper
• Mass Screening of Neonatal Hypothyroidism in Japan

  1980cited by this paper
• Neonatal thyroid screening

  1980cited by this paper
• Dried-blood spot screening for cystic fibrosis in the newborn.

  1979cited by this paper
• Screening for G. 6-P.D. deficiency.

  1976cited by this paper
• A surveillance system to prevent kernicterus in Singapore infants.

  1975cited by this paper
• Preliminary report on a mass screening program for neonatal hypothyroidism.

  1975cited by this paper
• Measurement of thyroid-stimulating hormone in dried blood spot.

  1975influential reference
• [Thyroxine (T4) determination by radioimmunological method in dried blood eluate: new diagnostic method of neonatal hypothyroidism?].

  1973cited by this paper
• Neonatal screening of phenylketonuria and congenital hypothyroidism in China.

  1971influential reference
• Screening for inborn errors of metabolism.

  1969cited by this paper
• Serological and immunological methods: Technical manual of the canadian red cross blood transfusion service

  1969cited by this paper
• Singapore kernicterus--the position in 1965.

  1965cited by this paper
• Singapore kernicterus--the position in 1965.

  1965cited by this paper
• A SIMPLE PHENYLALANINE METHOD FOR DETECTING PHENYLKETONURIA IN LARGE POPULATIONS OF NEWBORN INFANTS.

  1963cited by this paper

• Quantitative assessment of neonatal health using dried blood spot metabolite profiles and deep learning.

  2026cites this paper
• Revolutionizing neonatal health: India's journey from assays to advanced genetics.

  2025cites this paper
• Bridging Equity Gaps in Newborn Screening: Reflections on X-Linked Adrenoleukodystrophy (X-ALD) and Policy Implications for the Global South

  2025cites this paper
• Predicting variables associated with diagnostic reevaluation of transient congenital hypothyroidism

  2025cites this paper
• Lactate and pyruvate as inborn errors of metabolism screening markers and their analytical challenges—a review

  2025cites this paper
• The clinical and socioeconomic aspects of t-cell receptor excision circle based newborn screening for severe combined immunodeficiency in Southeast and East Asia

  2025cites this paper
• Newborn screening for congenital hypothyroidism: worldwide coverage 50 years after its start

  2025cites this paper
• Tandem mass spectrometry in screening for inborn errors of metabolism: comprehensive bibliometric analysis

  2025cites this paper
• Current Status of Newborn Bloodspot Screening Worldwide 2024: A Comprehensive Review of Recent Activities (2020–2023)

  2024cites this paper
• Experiences and Challenges with Congenital Hypothyroidism Newborn Screening in Indonesia: A National Cross-Sectional Survey

  2024cites this paper
• Consolidated Newborn Bloodspot Screening Efforts in Developing Countries in the Asia Pacific—2024

  2024cites this paper
• G6PD trait: societal importance to ensure well-being of female heterozygotes for health and childbirth

  2024cites this paper
• Newborn Screening for the Early Detection of Congenital Hypothyroidism: A Countrywide Comprehensive Program of Bangladesh Atomic Energy Commission

  2024cites this paper
• An insight into Indonesia's progress for newborn screening program: What is currently going on

  2024cites this paper
• Implementation factors of non-communicable disease policies and programmes for children and youth in low-income and middle-income countries: a systematic review

  2024cites this paper
• Newborn Screening in Developing Countries: The Need of the Hour

  2024influential citation
• Changing the standardised obstetric care by expanded carrier screening and counselling: a multicentre prospective cohort study

  2023cites this paper
• An Insight into Indonesia’s Challenges in Implementing Newborn Screening Programs and Their Future Implications

  2023cites this paper
• Expected Benefits and Challenges of Using Economic Evaluations to Make Decisions About the Content of Newborn Screening Programs in Vietnam: A Scoping Review of the Literature

  2023cites this paper
• Global prevalence of congenital hypothyroidism among neonates from 1969 to 2020: a systematic review and meta-analysis

  2023cites this paper
• OVERVIEW OF DUHOK/IRAQ PROJECT OF EXPANDED NEWBORN SCREENING

  2023cites this paper
• An Evaluation of a New Quantitative Point-of Care Diagnostic to Measure Glucose-6-phosphate Dehydrogenase Activity

  2022cites this paper
• Prevalence of Glucose-6-Phosphate Dehydrogenase Deficiency in Male Newborn Infants and Its Relationship with Neonatal Jaundice in Thailand

  2022cites this paper
• Successful Implementation of Expanded Newborn Screening in the Philippines Using Tandem Mass Spectrometry

  2022cites this paper
• Functional characterization of the p.(Gln195His) or Tainan and novel p.(Ser184Cys) or Toluca glucose-6-phosphate dehydrogenase (G6PD) gene natural variants identified through Mexican newborn screening for glucose-6-phosphate dehydrogenase deficiency.

  2022cites this paper
• Presenting status of children with classical congenital adrenal hyperplasia over two decades (1999–2018) in the absence of newborn screening in Sri Lanka

  2021cites this paper
• Applications of quantitative metabolomics to revolutionize early diagnosis of inborn errors of metabolism in India

  2021cites this paper
• Rare complication of hepatocellular carcinoma in Wilson's disease

  2021cites this paper
• Screening for aminoacidopathies using cost effective methods in symptomatic children: A cross sectional study

  2021cites this paper
• Establishment of a sustainable newborn TSH-screening program in the People's Democratic Republic of Laos.

  2021cites this paper
• We All Have a Role to Play: Redressing Inequities for Children Living with CAH and Other Chronic Health Conditions of Childhood in Resource-Poor Settings

  2020cites this paper
• Expanded Newborn Screening Program in Slovenia using Tandem Mass Spectrometry and Confirmatory Next Generation Sequencing Genetic Testing

  2020cites this paper
• A policy analysis of the national phenylketonuria screening program in Iran

  2020cites this paper
• The progression of salt‐wasting and the body weight change during the first 2 weeks of life in classical 21‐hydroxylase deficiency patients

  2020cites this paper
• Philippine Performance Evaluation and Assessment Scheme (PPEAS): Experiences in Newborn Screening System Quality Improvement

  2020cites this paper
• Pattern of Hemolytic Anemia Among Egyptian Pediatric Emergency Department Patients.

  2020cites this paper
• A policy Analysis of Phenylketonuria Screening National Program in Iran

  2020cites this paper
• A novel point-of-care device for measuring glucose-6-phosphate dehydrogenase enzyme deficiency.

  2020cites this paper
• Estimated Cost-effectiveness of Newborn Screening for Congenital Cytomegalovirus Infection in China Using a Markov Model

  2020cites this paper
• Prevalence of Congenital Hypothyroidism; in Rural Area of District Gautam Budha Nagar (U.P.)

  2019cites this paper
• Maximizing the Benefit of Life-Saving Treatments for Pompe Disease, Spinal Muscular Atrophy, and Duchenne Muscular Dystrophy Through Newborn Screening: Essential Steps.

  2019cites this paper
• Association of Newborn Screening Analytes with Type of Delivery Among Preterm and Term Births

  2019cites this paper
• Incidental screen positive findings in a prospective cohort study in Matlab, Bangladesh: insights into expanded newborn screening for low-resource settings

  2019cites this paper
• Asia Pacific Society of Human Genetics (APSHG) from conception to 2019: 13 years of collaboration to tackle congenital malformation and genetic disorders in Asia

  2019cites this paper
• Newborn Screening for Congenital Hypothyroidism, Congenital Adrenal Hyperplasia, and Glucose-6-Phosphate Dehydrogenase Deficiency for Improving Health Care in India

  2019cites this paper
• Neonatal thyroid screening for congential hypothyroidism

  2019cites this paper
• Interobserver Variability of Gleason Score and Completeness of Histopathology Report in Prostatic Adenocarcinoma in Prostate Needle Biopsy Specimens Among General Pathologists in a Multi-institutional Setting

  2018cites this paper
• Newborn Screening Guidelines for Congenital Hypothyroidism in India: Recommendations of the Indian Society for Pediatric and Adolescent Endocrinology (ISPAE) – Part II: Imaging, Treatment and Follow-up

  2018cites this paper
• Newborn Screening Guidelines for Congenital Hypothyroidism in India: Recommendations of the Indian Society for Pediatric and Adolescent Endocrinology (ISPAE) – Part I: Screening and Confirmation of Diagnosis

  2018cites this paper
• Simultaneous detection of multiple inherited metabolic diseases using GC-MS urinary metabolomics by chemometrics multi-class classification strategies.

  2018cites this paper
• Universal newborn screening: A roadmap for action.

  2018cites this paper
• Newborn screening in the developing countries

  2018cites this paper
• White Paper: Pathways to Progress in Newborn Screening for Sickle Cell Disease in Sub-Saharan Africa

  2018cites this paper
• Point-of-Care Testing for G6PD Deficiency: Opportunities for Screening

  2018influential citation
• Association Between udp-glucuronosyltransferase 1a1 (ugt1a1) Gene Polymorphism, (c.-3279t>g) and Phototherapy among Glucose-6-Phosphate Dehydrogenase (g6pd)-Deficient Neonates

  2018cites this paper
• The molecular epidemiology of Plasmodium spp. in Solomon Islands

  2018cites this paper
• Incidence of congenital hypothyroidism in China: data from the national newborn screening program, 2013–2015

  2018cites this paper
• Communication about Congenital Adrenal Hyperplasia: Perspective of Filipino Families

  2017cites this paper
• Expanded newborn metabolic screening programme in Hong Kong: a three-year journey.

  2017cites this paper
• New-born screening in large teaching hospital-six years of experience

  2017cites this paper
• The first Mongolian cases of phenylketonuria in selective screening of inborn errors of metabolism

  2016cites this paper
• Hypothermia and the Resuscitation of Asphyxiated Fetal Rhesus Monkeys

  2016cites this paper
• 50 Years Ago in The Journal of Pediatrics: Hypothermia and the Resuscitation of Asphyxiated Fetal Rhesus Monkeys.

  2016cites this paper
• Charles Darwin University Comparison of three screening test kits for G6PD enzyme deficiency Implications for its use in the radical cure of vivax malaria in remote and resource-poor areas in the philippines

  2016cites this paper
• Accurate prediction of gestational age using newborn screening analyte data.

  2016cites this paper
• National G6PD neonatal screening program in Gaza Strip of Palestine: rationale, challenges and recommendations

  2016cites this paper
• Prospective Surveillance of Extreme Neonatal Hyperbilirubinemia in Australia.

  2016cites this paper
• Newborn Screening for Congenital Adrenal Hyperplasia in India: What Do We Need to Watch Out for?

  2016cites this paper
• Household financial burden of phenylketonuria and its impact on treatment in China: a cross-sectional study

  2016cites this paper
• Access, availability, and infrastructure deficiency: The current management of thyroid disease in the developing world

  2016cites this paper
• Challenges of Implementation of the National Phenylketonuria Screening Program in Iran: A Qualitative Study

  2016cites this paper
• Incidence and molecular characterization of Glucose‐6‐Phosphate Dehydrogenase deficiency among neonates for newborn screening in Chaozhou, China

  2015cites this paper
• Pediatric Provider Insight Into Newborn Screening for Glucose-6-Phosphate Dehydrogenase Deficiency

  2015cites this paper
• Newborn Screening in Slovenia

  2015cites this paper
• Current status of newborn screening worldwide: 2015.

  2015influential citation
• Newborn screening for congenital adrenal hyperplasia in Tokyo, Japan from 1989 to 2013: a retrospective population-based study

  2015cites this paper
• Parental education and the WHO neonatal G-6-PD screening program: a quarter century later

  2015cites this paper
• Diagnostic and management practices for phenylketonuria in 19 countries of the South and Eastern European Region: survey results

  2015cites this paper
• Evaluation of TSH Levels in the Program of Congenital Hypothyroidism Newborn Screening in a Pilot Study of Preterm Newborns in Bogotá, Colombia

  2015cites this paper
• Benefits and burdens of newborn screening: public understanding and decision-making.

  2014cites this paper
• The α-thalassemias.

  2014cites this paper
• Present status and future concerns of expanded newborn screening in malaysia: sustainability, challenges and perspectives.

  2014cites this paper
• Inborn Errors of Metabolism

  2014cites this paper
• Screening for congenital hypothyroidism: a worldwide view of strategies.

  2014cites this paper
• Should blood donors be routinely screened for glucose-6-phosphate dehydrogenase deficiency? A systematic review of clinical studies focusing on patients transfused with glucose-6-phosphate dehydrogenase-deficient red cells.

  2014cites this paper
• Considering consent: a structural equation modelling analysis of factors influencing decisional quality when accepting newborn screening

  2014cites this paper
• bloodspot screening : a study protocol application of informed consent for newborn Stakeholder attitudes towards the role and and

  2014cites this paper
• Barriers to implementing sustainable national newborn screening in developing health systems

  2014cites this paper
• Journal of Genetic Disorders & Genetic Reports Phenylketonuria (PKU) - What Next? Mini-Review

  2014cites this paper
• Metabolomics of prematurity: analysis of patterns of amino acids, enzymes, and endocrine markers by categories of gestational age

  2014cites this paper
• Pediatric hypoglycemia.

  2014cites this paper
• Newborn Screening for Congenital Hypothyroidism in India- Is OVERDUE

  2014cites this paper
• Newborn screening in southeastern Europe.

  2014cites this paper
• Selective Screening for Metabolic Disorders in the Slovenian Pediatric Population

  2014cites this paper
• Indicators of newborn screening for congenital hypothyroidism in Sri Lanka: program challenges and way forward

  2014cites this paper
• Stakeholder attitudes towards the role and application of informed consent for newborn bloodspot screening: a study protocol

  2014cites this paper
• G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests

  2013cites this paper
• Establishment of the first newborn screening program in the People's Democratic Republic of Laos.

  2013influential citation
• Should we screen newborns for glucose-6-phosphate dehydrogenase deficiency in the United States?

  2013cites this paper
• Review of key knowledge gaps in glucose-6-phosphate dehydrogenase deficiency detection with regard to the safe clinical deployment of 8-aminoquinoline treatment regimens: a workshop report

  2013cites this paper